Trial now

Inflation Concerns Underpin Bear Steepening


Bullish Theme


Firm Within Its Bull Channel

Sign up now for free access to this content.

Please enter your details below and select your areas of interest.

  • Markets read concern into Johnson & Johnson's decision to delay and stall the rollout of their COVID-19 vaccine across Europe, with the US CDC also deciding to pause the jab's use domestically over blood-clotting concerns.
  • In response, the three main US indices slipped sharply alongside J&J shares, which fell as much as 3% and dragged on the Dow Jones Industrial Average, which traded lower against minor gains for the S&P 500 and NASDAQ. Utilities, consumer discretionary and tech outperformed, while financials and industrials lagged.
  • The e-mini S&P wholly erased the initial vaccine-induced dip, which was preceded by a new all time high, keeping the recent run of strength very much in tact. The index trades with month-to-date gains of close to 4%.
  • Earnings season kicks off materially Wednesday, with JPMorgan, Goldman Sachs and Wells Fargo all reporting.